Work

P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry

Year: 2021

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(21)02263-1

Authors: Lynne Wagner, Rafat Abonour, Sikander Ailawadhi, Brian G.M. Durie, Cristina J. Gasparetto, James W. Hardin, Hans Lee, Mohit Narang, Robert Rifkin, Howard Terebelo, Kathleen Toomey, Prashant Joshi, Amit Agarwal, Julia Braverman, Devender S. Dhanda, Mia He, Sundar Jagannath

Institutions: Wake Forest University, Indiana University, Mayo Clinic, Cedars-Sinai Medical Center, Duke Medical Center, University of South Carolina, The University of Texas MD Anderson Cancer Center, Maryland Oncology Hematology, Rocky Mountain Cancer Centers, Bristol-Myers Squibb (United States), Mount Sinai Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3214655374

Cites:

Cited by:

Related to: 10